An accomplished scientist and pharmaceutical executive with 25 years of experience in drug discovery and development focusing on diseases of the central nervous system. Demonstrated leadership in setting strategies, innovative research as well as managing a comprehensive portfolio and a multi-disciplinary global team. Having conducted/directed research from drug target identification/validation through lead optimization, clinical candidate selection and early clinical trials with a proven track record of achieving business objectives. Extensive experience in collaborations with multiple local/international academic investigators, biotech companies and non-profit disease consortia including evaluation of business development opportunities.